• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Adv . Mitochondrial OXPHOS restricts SARS-CoV-2 replication

tetano

Editor, Senior Moderator
Sci Adv


. 2026 Jun 5;12(23):eadz3081.
doi: 10.1126/sciadv.adz3081. Epub 2026 Jun 3.
Mitochondrial OXPHOS restricts SARS-CoV-2 replication

Yentli E Soto Albrecht[SUP] 1 2 3 4 [/SUP], Ryan M Morrow[SUP] 1 [/SUP], Devin Kenney[SUP] 3 4 [/SUP], Arnold Z Olali[SUP] 1 [/SUP], Alan Wacquiez[SUP] 4 5 [/SUP], Nader Chehadeh[SUP] 3 4 6 [/SUP], Zimu Cen[SUP] 1 7 [/SUP], Jeffrey A Haltom[SUP] 1 [/SUP], Ian Chen[SUP] 1 [/SUP], Sujata S Ranshing[SUP] 1 [/SUP], Gabrielle A Widjaja[SUP] 1 [/SUP], Alessia Angelin[SUP] 1 [/SUP], Jesus A Tintos-Hernandez[SUP] 1 [/SUP], Wanqing Xie[SUP] 1 [/SUP], Prasanth Potluri[SUP] 1 [/SUP], Marie T Lott[SUP] 1 [/SUP], Shiping Zhang[SUP] 1 8 [/SUP], Mohsan Saeed[SUP] 4 5 [/SUP], Deborah G Murdock[SUP] 1 9 [/SUP], Susan R Weiss[SUP] 2 [/SUP], Florian Douam[SUP] 3 4 [/SUP], Douglas C Wallace[SUP] 1 9 [/SUP]


Affiliations
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rewires host metabolism to optimize virus production. Although glycolysis is necessary for virus production, the importance of mitochondrial oxidative phosphorylation (OXPHOS) is unknown. The mitochondrial DNA (mtDNA) codes for 13 critical OXPHOS polypeptides plus the 22 transfer RNAs (tRNAs) and 2 ribosomal RNAs (rRNAs) for mitochondrial protein synthesis. We found an ∼5- to 100-fold greater SARS-CoV-2 virus production in infected human ACE2-expressing A549 lung cells when OXPHOS was inhibited by mtDNA depletion (ρ[SUP]0[/SUP] cells), inhibition of mitochondrial translation with chloramphenicol (CAP), or chemical inhibition of OXPHOS complexes. OXPHOS inhibition led to a marked increase in the size and distribution of viral replication centers and accelerated the production and release of infectious particles, occurring ∼2 hours earlier than in parental A549-ACE2 (wild type) cells. Subsequently, we found that increased glycolytic capacity was required for enhanced viral replication whereas differences in innate immune pathway activation were not. Reintroduction of mtDNA from a well-defined maternal lineage into the ρ[SUP]0[/SUP] cells reinstated OXPHOS, impaired SARS-CoV-2 replication, and reversed associated viral and glycolytic correlates. Thus, metabolic balance regulates SARS-CoV-2 replication, with OXPHOS exerting an antiviral effect.


 
Back
Top